Why is LENZ Therapeutics, Inc. ?
1
Flat results in Sep 25
- OPERATING PROFIT(Q) Lowest at USD -18.76 MM
- PRE-TAX PROFIT(Q) Lowest at USD -16.7 MM
- NET PROFIT(Q) Lowest at USD -16.7 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -49.38%, its profits have fallen by -4.8%
3
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 12.95% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -49.38% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
107.39%
EBIT Growth (5y)
-10.65%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.91%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.02
EV to EBIT
-13.34
EV to EBITDA
-13.36
EV to Capital Employed
-296.66
EV to Sales
165.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-25.39%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bearish
Technical Movement
10What is working for the Company
NET PROFIT(HY)
Higher at USD -31.61 MM
RAW MATERIAL COST(Y)
Fallen by -9,900% (YoY
NET SALES(9M)
Higher at USD 17.5 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 0.43 times
-12What is not working for the Company
OPERATING PROFIT(Q)
Lowest at USD -18.76 MM
PRE-TAX PROFIT(Q)
Lowest at USD -16.7 MM
NET PROFIT(Q)
Lowest at USD -16.7 MM
EPS(Q)
Lowest at USD -0.59
Here's what is working for LENZ Therapeutics, Inc.
Net Sales
At USD 17.5 MM has Grown at inf%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 0.43 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Higher at USD 17.5 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Raw Material Cost
Fallen by -9,900% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for LENZ Therapeutics, Inc.
Operating Profit
Lowest at USD -18.76 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -16.7 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -16.7 MM has Fallen at -28.72%
over average net sales of the previous four periods of USD -12.97 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -16.7 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
At USD -16.7 MM has Fallen at -27.49%
over average net sales of the previous four periods of USD -13.1 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.59
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)






